Literature DB >> 27477604

Challenging dogma: is hepatic lipid accumulation in type 2 diabetes due to mitochondrial dysfunction?

Christopher G R Perry1, David C Wright2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27477604      PMCID： PMC4967746          DOI： 10.1113/JP272573

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  8 in total

1.  Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model.

Authors:  R Scott Rector; John P Thyfault; Grace M Uptergrove; E Matthew Morris; Scott P Naples; Sarah J Borengasser; Catherine R Mikus; Matthew J Laye; M Harold Laughlin; Frank W Booth; Jamal A Ibdah
Journal:  J Hepatol       Date:  2010-03-04       Impact factor: 25.083

2.  Mitochondrial dysfunction and type 2 diabetes.

Authors:  Bradford B Lowell; Gerald I Shulman
Journal:  Science       Date:  2005-01-21       Impact factor: 47.728

3.  Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model.

Authors:  R Scott Rector; Grace M Uptergrove; E Matthew Morris; Sarah J Borengasser; M Harold Laughlin; Frank W Booth; John P Thyfault; Jamal A Ibdah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

4.  Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats.

Authors:  Melissa A Linden; Justin A Fletcher; E Matthew Morris; Grace M Meers; Monica L Kearney; Jacqueline M Crissey; M Harold Laughlin; Frank W Booth; James R Sowers; Jamal A Ibdah; John P Thyfault; R Scott Rector
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-10       Impact factor: 4.310

5.  Liver adapts mitochondrial function to insulin resistant and diabetic states in mice.

Authors:  Andras Franko; Jürgen-Christoph von Kleist-Retzow; Susanne Neschen; Moya Wu; Philipp Schommers; Marlen Böse; Alexander Kunze; Ursula Hartmann; Carmen Sanchez-Lasheras; Oliver Stoehr; Michael Huntgeburth; Susanne Brodesser; Martin Irmler; Johannes Beckers; Martin Hrabé de Angelis; Mats Paulsson; Markus Schubert; Rudolf J Wiesner
Journal:  J Hepatol       Date:  2013-11-28       Impact factor: 25.083

6.  Hepatic mitochondrial oxidative phosphorylation is normal in obese patients with and without type 2 diabetes.

Authors:  Michael Taulo Lund; Marianne Kristensen; Merethe Hansen; Louise Tveskov; Andrea Karen Floyd; Mikael Støckel; Ben Vainer; Steen Seier Poulsen; Jørn Wulff Helge; Clara Prats; Flemming Dela
Journal:  J Physiol       Date:  2016-08-01       Impact factor: 5.182

7.  Abnormal hepatic energy homeostasis in type 2 diabetes.

Authors:  Julia Szendroedi; Marek Chmelik; Albrecht Ingo Schmid; Peter Nowotny; Attila Brehm; Martin Krssak; Ewald Moser; Michael Roden
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

8.  Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.

Authors:  Albrecht Ingo Schmid; Julia Szendroedi; Marek Chmelik; Martin Krssák; Ewald Moser; Michael Roden
Journal:  Diabetes Care       Date:  2011-01-07       Impact factor: 19.112
  8 in total
  1 in total

1.  MicroRNA‑802 increases hepatic oxidative stress and induces insulin resistance in high‑fat fed mice.

Authors:  Xi Yang; Hanying Xing; Jingzhen Liu; Linquan Yang; Huan Ma; Huijuan Ma
Journal:  Mol Med Rep       Date:  2019-06-05       Impact factor: 2.952
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.